The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, but its position within the broader sector now raises questions about long-term returns . Alternative versions are eroding exclusivity , causing concerns that betting on companies significantly dependent to Viagra's former standing could be a dangerous d